Exosome brain conveying device based on nasal delivery

By adopting a modular structural design and an ergonomic grip mechanism, the problems of drug residue and unstable grip in nasal delivery devices have been solved, achieving efficient atomization and precise delivery of exosome drugs.

CN121102703APending Publication Date: 2025-12-12WEST CHINA HOSPITAL SICHUAN UNIV +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511575693.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-10-31
Publication Date
2025-12-12

AI Technical Summary

Technical Problem

Nasal delivery devices are prone to drug residue and blockage during repeated use, and their design is not ergonomic, resulting in inaccurate drug delivery and a poor user experience.

Method used

It adopts a modular structural design, anti-clogging nozzle, and ergonomic grip mechanism, including a drug delivery mechanism, a drug carrying mechanism, and a grip mechanism. It utilizes a composite sealing structure of magnetic sleeve and magnetic ring, and sets micro spiral grooves on the inner wall of the nozzle. Combined with the biomimetic hinge structure of the thumb grip and middle finger grip, it forms a multi-point anti-slip contact.

Benefits of technology

It effectively prevents nozzle clogging, improves the stability and accuracy of drug delivery, and enhances the user experience.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121102703A_ABST
    Figure CN121102703A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of drug delivery devices, and discloses a nasal delivery-based exosome brain delivery device, which comprises a drug bearing mechanism and a delivery mechanism positioned above the drug bearing mechanism, the delivery mechanism includes a hose for delivering a solution. A composite sealing structure of a magnetic suction sleeve and a magnetic suction ring is adopted for the quick release assembly, the self-closing design of a duckbill valve is matched, the problem of nozzle blockage caused by exosome solution residues is effectively solved, a miniature spiral groove formed in the inner wall of the nozzle remarkably reduces adhesion of viscous medicine to the tube wall by generating a centrifugal force field, and the effect of medicine spraying is improved. The holding mechanism innovatively adopts a bionic hinge structure of a thumb holding rod and a middle finger holding rod, an adjustable friction surface is formed by combining a magnetic suction sliding sheet in a limiting groove channel, multi-point anti-skid contact is formed on the surface of the device in cooperation with the automatic weight balancing function of a gravity balancing assembly, and the problem that a traditional device is unstable in holding is solved; the stability and the precision of the exosome in the nasal delivery process are obviously improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the technical field of drug delivery devices, and more particularly to an exosome brain delivery device based on nasal delivery. Background Technology

[0002] In recent years, targeted therapies for brain diseases have faced the natural delivery barrier of the blood-brain barrier (BBB). Nasal delivery has become a research hotspot due to its non-invasive nature and ability to bypass the BBB, while exosomes, with their natural nanoscale size, low immunogenicity, and barrier-crossing capabilities, are considered ideal brain delivery carriers. This technology utilizes the olfactory region / trigeminal nerve pathway in the nasal cavity, modifying or loading exosomes to achieve targeted drug delivery via the nasal-brain axis. Its feasibility has been validated in animal models of Alzheimer's disease and Parkinson's disease.

[0003] Currently, due to the special viscous properties of exosome solutions, nasal delivery devices are prone to drug residue and clogging during repeated use, directly affecting the uniformity of spray and the accuracy of dosage. Secondly, the device's shape design does not fully consider ergonomic factors, with an overly smooth surface and a lack of effective anti-slip structure, which makes it easy for users to have an unstable grip during operation, thus affecting the accuracy of the drug delivery process and the user experience. Summary of the Invention

[0004] In view of the problems of existing nasal delivery-based exosome brain delivery devices, the present invention is proposed.

[0005] Therefore, the purpose of this invention is to provide an exosome brain delivery device based on nasal delivery, which aims to achieve efficient atomization, stable delivery and precise delivery of exosome drugs through modular structural design, anti-clogging nozzle and ergonomic grip mechanism.

[0006] To solve the above-mentioned technical problems, the present invention provides the following technical solution: including a drug carrier mechanism and a delivery mechanism located above the drug carrier mechanism; The delivery mechanism includes a hose for conveying a solution, a quick-release assembly disposed at one end of the hose, a nozzle movably connected to the outside of the quick-release assembly, and a micro spiral groove formed on the inner wall of the nozzle. And a gripping mechanism used in conjunction with the delivery mechanism.

[0007] As a preferred embodiment of the exosome brain delivery device based on nasal delivery according to the present invention, the drug delivery mechanism includes a reservoir and a sustained-release buffer fixedly installed at the center of the top of the reservoir.

[0008] As a preferred scheme of the exosome brain delivery device based on nasal delivery, wherein: the drug carrying mechanism further comprises a piezoelectric atomization pipe fixedly installed at the top of the slow-release buffer, an adjusting knob hingedly connected at the end of the piezoelectric atomization pipe, and a micro air pump fixedly installed at the top of the piezoelectric atomization pipe.

[0009] As a preferred scheme of the exosome brain delivery device based on nasal delivery, wherein: the other end of the hose is fixedly connected with the top of the micro air pump and communicates with each other.

[0010] As a preferred scheme of the exosome brain delivery device based on nasal delivery, wherein: the quick release assembly comprises a magnetic suction sleeve fixedly installed at the end of the hose, and a magnetic suction ring fixedly installed in the inner cavity of the magnetic suction sleeve.

[0011] As a preferred scheme of the exosome brain delivery device based on nasal delivery, wherein: the quick release assembly further comprises a cannula movably inserted in the inner cavity of the magnetic suction sleeve, and a duckbill valve fixedly installed at the end of the cannula.

[0012] As a preferred scheme of the exosome brain delivery device based on nasal delivery, wherein: the holding mechanism comprises a thumb holding rod, a middle finger holding rod hingedly connected at the end of the thumb holding rod, and a gravity balance assembly arranged on the outer side of the middle finger holding rod.

[0013] As a preferred scheme of the exosome brain delivery device based on nasal delivery, wherein: the holding mechanism further comprises a limiting groove opened on the outer side of the middle finger holding rod, a groove plate fixedly installed on the outer side of the middle finger holding rod, a magnetic suction sliding plate movably clamped in the inner cavity of the groove plate, a through hole opened in the inner cavity of the middle finger holding rod, a damping shaft sleeve hingedly connected at the end of the thumb holding rod, and a limiting clamping sleeve hingedly connected at the top of the damping shaft sleeve, the limiting clamping sleeve movably sleeving the end of the hose close to the delivery mechanism.

[0014] As a preferred scheme of the exosome brain delivery device based on nasal delivery, wherein: the gravity balance assembly comprises a movable rod movably clamped in the inner cavity of the through hole, and a limiting clamping ring fixedly sleeving the outer side of the movable rod.

[0015] As a preferred scheme of the exosome brain delivery device based on nasal delivery, wherein: the gravity balance assembly further comprises a reset spring fixedly installed on the outer side of the limiting clamping ring, and a supporting holding rod fixedly installed at the end of the reset spring.

[0016] The beneficial effects of the present application: through the quick release assembly adopts the composite sealing structure of magnetic attraction sleeve and magnetic attraction ring, cooperates with the self-closing design of the duckbill valve, effectively prevents the nozzle blockage problem caused by the exosome solution residue, the micro spiral groove arranged on the inner wall of the nozzle generates a centrifugal field, significantly reduces the adhesion of viscous drugs on the pipe wall, the innovative bionic hinge structure of the thumb holding rod and the middle finger holding rod is adopted, the adjustable friction surface is formed by combining the magnetic attraction sliding sheet in the limiting groove, the automatic counterweight function of the gravity balance assembly is matched, the multi-point anti-skid contact is formed on the surface of the device, solves the problem of unstable holding of the traditional device, and the stability and precision of the exosome nasal delivery process are significantly improved. BRIEF DESCRIPTION OF DRAWINGS

[0017] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings needed in the embodiment description will be briefly introduced as follows. Obviously, the drawings in the following description are only some embodiments of the present application, and other drawings can be obtained by those skilled in the art without creative labor. Among them: Figure 1 It is the overall structure schematic diagram of the present application.

[0018] Figure 2 It is the holding mechanism structure schematic diagram of the present application.

[0019] Figure 3 It is the quick release assembly structure partial cross-sectional view of the present application.

[0020] Figure 4 It is the holding mechanism and gravity balance assembly structure cross-sectional view of the present application.

[0021] Figure 5 It is the quick release assembly structure partial exploded schematic diagram of the present application.

[0022] Figure 6 It is the holding mechanism structure partial schematic diagram of the present application.

[0023] In the figure: 100, drug carrying mechanism; 110, liquid storage bin; 120, slow-release buffer; 130, piezoelectric atomizing pipe; 140, adjusting knob; 150, micro air pump; 200, delivery mechanism; 210, hose; 220, quick release assembly; 221, magnetic attraction sleeve; 222, magnetic attraction ring; 223, cannula; 224, duckbill valve; 230, nozzle; 240, micro spiral groove; 300, holding mechanism; 310, thumb holding rod; 320, middle finger holding rod; 330, gravity balance assembly; 331, movable rod; 332, limiting ring; 333, reset spring; 334, supporting holding rod; 340, limiting groove; 350, slot plate; 360, magnetic slide; 370, through hole; 380, damping sleeve; 390, limiting sleeve. DETAILED DESCRIPTION

[0024] In order to make the above objectives, features and advantages of the present application more obvious and easy to understand, the specific embodiments of the present application will be described in detail below with reference to the accompanying drawings.

[0025] In the following description, a lot of specific details are set forth in order to provide a thorough understanding of the present application, but the present application can also be implemented in other ways different from those described herein, and those skilled in the art can make similar generalizations without departing from the concept of the present application, therefore the present application is not limited to the specific embodiments disclosed below.

[0026] Secondly, the "one embodiment" or "embodiment" referred to herein means that the specific features, structures or characteristics can be included in at least one implementation of the present application. "In one embodiment" appearing in different places in the specification does not mean the same embodiment, nor is it an independent or alternative embodiment that excludes other embodiments.

[0027] Thirdly, the present application is described in detail in conjunction with the schematic diagram, and in the detailed description of the embodiments of the present application, the cross-sectional view of the device structure is partially enlarged without general proportion for the convenience of description, and the schematic diagram is only an example, which should not limit the scope of protection of the present application. In addition, three-dimensional spatial dimensions including length, width and depth should be included in actual manufacture.

[0028] Embodiment 1 Reference Figures 1-6 For the first embodiment of the present application, an exosome brain delivery device based on nasal cavity delivery is provided, which comprises a drug carrying mechanism 100 and a delivery mechanism 200 located above the drug carrying mechanism 100; The delivery mechanism 200 comprises a hose 210 for delivering solution, a quick release assembly 220 arranged at one end of the hose 210, a nozzle 230 movably connected to the outside of the quick release assembly 220, and a micro spiral groove 240 opened in the inner wall of the nozzle 230; And a holding mechanism 300 used in cooperation with the delivery mechanism 200.

[0029] The drug carrying mechanism 100 and the delivery mechanism 200 are arranged in an upper and lower split mode, the modular separation of the drug storage and delivery functions is realized, the maintenance and disinfection of the device are facilitated, the nozzle 230 with a micro spiral groove 240 is combined with the quick release assembly 220, the stable vortex of the atomized drug is ensured, the disassembly process of the nozzle 230 is simplified, and the holding mechanism 300 is added to provide an ergonomic operation basis for the overall device.

[0030] Specifically, the drug carrying mechanism 100 includes a liquid storage bin 110 and a slow-release buffer 120 fixedly installed at the top center of the liquid storage bin 110, and further includes a piezoelectric atomization pipe 130 fixedly installed at the top of the slow-release buffer 120, an adjusting knob 140 hingedly connected at the end of the piezoelectric atomization pipe 130, and a micro air pump 150 fixedly installed at the top of the piezoelectric atomization pipe 130. The other end of the hose 210 is fixedly connected to the top of the micro air pump 150 and communicates with each other.

[0031] The hierarchical layout of the liquid storage bin 110 and the slow-release buffer 120 enables the exosome solution to first stabilize the physicochemical properties through the slow-release buffer 120 before entering the delivery link, effectively avoiding the inactivation of the active ingredients of the drug due to sudden pressure changes. The structure of the slow-release buffer 120 arranged in the middle ensures that the drug can flow uniformly into the downstream atomization assembly. The vertical stacking design of the piezoelectric atomization pipe 130 and the micro air pump 150 realizes the dual functions of drug atomization and delivery in a limited space. The hinged structure of the adjusting knob 140 enables users to accurately control the atomization particle size according to individual needs, and the top positioning of the micro air pump 150 forms an optimal airflow conduction path. The straight connection structure of the hose 210 and the top of the micro air pump 150 eliminates the airflow loss problem caused by traditional lateral connection. This layout enables the atomized drug to enter the delivery channel along the shortest path, significantly reducing the adhesion loss of the drug during transmission.

[0032] Further, the quick release assembly 220 includes a magnetic sleeve 221 fixedly installed at the end of the hose 210, and a magnetic ring 222 fixedly installed in the inner cavity of the magnetic sleeve 221. The quick release assembly 220 further includes a plug 223 movably inserted into the inner cavity of the magnetic sleeve 221, and a duckbill valve 224 fixedly installed at the end of the plug 223.

[0033] The quick disassembly assembly 220 is fixed by double magnetic attraction of the magnetic attraction sleeve 221 and the magnetic attraction ring 222, which ensures the sealing connection and realizes the one-handed quick disassembly of the nozzle 230. The structure is suitable for clinical application scenarios that require frequent replacement of the nozzle 230. The combination design of the cannula 223 and the duckbill valve 224 maintains the rigid support of the delivery pipeline through the plug-in structure and prevents drug backflow and external pollution by using the self-closing characteristics of the duckbill valve 224, which double guarantees the hygiene and safety of the delivery system.

[0034] In use, first, the exosome drug solution is injected into the storage tank 110, and after being stabilized by the slow-release buffer 120, it enters the piezoelectric atomization tube 130. The atomization particle size is controlled by adjusting the knob 140, and airflow is generated by the micro air pump 150. The atomized drug is delivered to the delivery mechanism 200 through the hose 210, and the duckbill valve 224 in the quick disassembly assembly 220 prevents backflow. Finally, the nozzle 230 with a micro spiral groove 240 forms a vortex and is precisely sprayed into the nasal cavity. During the entire process, the holding mechanism 300 automatically adjusts the center of gravity through the gravity balance assembly 330 to ensure delivery stability and operation comfort, achieving efficient and precise brain targeting delivery of exosome drugs.

[0035] In summary, the drug carrying mechanism 100 adopts a hierarchical layout of the storage tank 110 and the slow-release buffer 120 to ensure the stability of the drug activity, and cooperates with the vertically stacked piezoelectric atomization tube 130 and the micro air pump 150 connected at the top to achieve efficient atomization. The delivery mechanism 200 generates a stable vortex through the nozzle 230 with a micro spiral groove 240, and combines the magnetic quick disassembly assembly 220 and the duckbill valve 224 to ensure sealing and facilitate disassembly. The ergonomic holding mechanism 300 improves operation stability and comfort through gravity balance and adjustable design, and finally realizes precise control and efficient delivery of the entire process from storage, atomization to nasal cavity targeting delivery of exosome drugs.

[0036] Example 2 Referring to Figure 1 , Figure 2 , Figure 4 and Figure 6 , the second embodiment of the present application is different from the first embodiment in that it provides a holding mechanism 300 that optimizes holding stability and operation adaptability.

[0037] Further, the holding mechanism 300 comprises a thumb holding rod 310, a middle finger holding rod 320 hinged at the end of the thumb holding rod 310, and a gravity balance assembly 330 arranged outside the middle finger holding rod 320. The holding mechanism 300 further comprises a limiting groove 340 opened outside the middle finger holding rod 320, a groove plate 350 fixedly installed outside the middle finger holding rod 320, a magnetic slide 360 movably clamped in the inner cavity of the groove plate 350, a through hole 370 opened in the inner cavity of the middle finger holding rod 320, a damping shaft sleeve 380 hinged at the end of the thumb holding rod 310, and a limiting clamping sleeve 390 hinged at the top of the damping shaft sleeve 380, which movably clamps the end of the hose 210 close to the delivery mechanism 200.

[0038] The hinge structure of the thumb holding rod 310 and the middle finger holding rod 320 simulates the natural holding posture of the human body, and the gravity balance assembly 330 dynamically adjusts the center of gravity of the device. The combination design significantly improves the single-hand holding stability, especially for patients with hand tremors of Parkinson's disease. The adjustable holding surface formed by the limiting groove 340 and the magnetic slide 360, combined with the slow rotation characteristics of the damping shaft sleeve 380, enables the device to adapt to users with different palm sizes. The flexible fixation of the limiting clamping sleeve 390 to the hose 210 not only avoids pipe bending but also reduces the interference of operation vibration on drug delivery.

[0039] Further, the gravity balance assembly 330 comprises a movable rod 331 movably clamped in the inner cavity of the through hole 370, and a limiting clamping ring 332 fixedly clamped outside the movable rod 331. The gravity balance assembly 330 further comprises a return spring 333 fixedly installed outside the limiting clamping ring 332, and a supporting holding rod 334 fixedly installed at the end of the return spring 333.

[0040] The sliding cooperation of the movable rod 331 in the through hole 370 with the constraint of the limiting clamping ring 332 constitutes a self-adaptive counterweight mechanism, which can automatically adjust the balance moment according to the inclination angle of the device, ensuring that the stable spraying trajectory can be maintained in different operation postures. The elastic connection design of the return spring 333 and the supporting holding rod 334 provides sufficient holding resistance while absorbing accidental impact force during operation through spring deformation, ensuring accurate drug delivery and avoiding mechanical damage caused by excessive force.

[0041] In use, the patient holds the device with one hand, the thumb and the middle finger naturally fit the thumb holding rod 310 and the middle finger holding rod 320, the gravity balance assembly 330 adjusts the center of gravity of the device in real time to adapt to the change of the operation angle, the damping shaft sleeve 380 and the limiting clamping sleeve 390 cooperate to stabilize the hose 210, ensuring that the drug delivery process is not affected by slight hand tremors. The magnetic slide 360 can adjust the holding position according to the needs, further optimizing the operation comfort.

[0042] In summary, the ergonomic holding structure and dynamic balance system of the holding mechanism 300 significantly improve the stability and adaptability of the device, making the brain delivery process of exosomes more precise and reliable.

[0043] Embodiment 3 Reference Figures 1-6 For the third embodiment of the present application, unlike the previous embodiment, this embodiment provides a use method, including an exosome brain delivery device based on nasal delivery, the method comprising the following steps: S1: Inject the exosome drug solution into the storage tank 110, ensure that the slow-release buffer 120 is connected stably with the piezoelectric atomization tube 130, check the airtightness of the quick-release assembly 220 and the nozzle 230, and adjust the holding mechanism 300 to a suitable holding position for the user; S2: Set appropriate atomization parameters by adjusting the knob 140, start the micro air pump 150 and the piezoelectric atomization tube 130, so that the drug solution forms uniform micron-sized atomized particles in the piezoelectric atomization tube 130, and the atomized drug is transported to the delivery mechanism 200 through the hose 210; S3: Align the nozzle 230 with the entrance of the user's nasal cavity, and the gravity balance assembly 330 of the holding mechanism 300 automatically adjusts the center of gravity of the device to maintain a stable delivery angle, ensuring that the atomized drug is accurately guided to the olfactory region along the nasal passage; S4: Turn on the delivery switch, the atomized drug forms a rotating air flow under the guidance of the micro spiral groove 240, enters the nasal cavity at a stable flow rate and direction through the one-way flow characteristic of the duckbill valve 224, is absorbed by the nasal mucosa and then targeted to the brain target area, and the power of the device is turned off after the drug delivery process is completed, and the nozzle 230 is disassembled for cleaning and disinfection.

[0044] In summary, the use method optimizes the operation process and the cooperative working mode of the device, and realizes precise control of the whole process from loading, atomization to brain targeted delivery of exosome drugs.

[0045] It is important to note that the construction and arrangement of the application shown in the various exemplary embodiments is illustrative only. Although only a few embodiments have been described in detail in this disclosure, those skilled in the art who review the present disclosure will readily appreciate that many modifications are possible (e.g., variations in sizes, dimensions, structures, shapes and proportions of the various elements, values of parameters, mounting arrangements, use of materials, colors, orientations, etc.) without materially departing from the novel teachings and advantages of the subject matter described herein. For example, elements shown as integrally formed can be constructed of multiple parts or elements, the position of elements can be reversed or otherwise varied, and the nature or number of elements can be altered or varied. Thus, the foregoing description is not intended to be taken in a limiting sense, but is made solely for illustration rather than limitation. All such modifications are intended to be included within the scope of the present application. The order or sequence of any process or method steps can be varied or re-sequenced without departing from the subject matter. Any "process" or "method" steps can be carried out simultaneously, concurrently, or in different order than as described. The application is to be limited only by the claims included herein and equivalents thereof. In the claims, any means-plus-function clause is intended to cover the structures described herein as performing the recited function and also material or equivalents equivalent thereto. Other substitutions, modifications, changes and omissions can be made in the design, operating conditions and arrangement of the exemplary embodiments without departing from the scope of the present application. Accordingly, the present application is not limited to the particular embodiments described herein, but extends to all constructions that fall within the scope of the appended claims, and equivalents thereof.

[0046] Furthermore, in order to provide a concise description of exemplary embodiments, not all features of an actual implementation can be described (i.e., those related to the

[0047] It should be noted that the above-mentioned embodiments are only used to illustrate the technical solutions of the present application, but not limit the present application. Although the present application is described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solutions of the present application can be modified or equivalent replaced without departing from the spirit and scope of the present application, which should be covered in the scope of the claims of the present application.

Claims

1. A nasal delivery device for exosomes to the brain, characterized in that: It includes a drug delivery unit (100) and a delivery unit (200) located above the drug delivery unit (100). The delivery mechanism (200) includes a hose (210) for delivering a solution, a quick-release assembly (220) disposed at one end of the hose (210), a nozzle (230) movably connected to the outside of the quick-release assembly (220), and a micro spiral groove (240) formed on the inner wall of the nozzle (230). And a gripping mechanism (300) used in conjunction with the delivery mechanism (200).

2. The exosome brain delivery device based on nasal delivery according to claim 1, characterized in that: The drug delivery system (100) includes a reservoir (110) and a sustained-release buffer (120) fixedly installed at the center of the top of the reservoir (110).

3. The exosome brain delivery device based on nasal delivery according to claim 2, characterized in that: The drug delivery mechanism (100) also includes a piezoelectric nebulizer tube (130) fixedly mounted on the top of the sustained-release buffer (120), an adjustment knob (140) hinged to the end of the piezoelectric nebulizer tube (130), and a miniature air pump (150) fixedly mounted on the top of the piezoelectric nebulizer tube (130).

4. The exosome brain delivery device based on nasal delivery according to claim 3, characterized in that: The other end of the hose (210) is fixedly connected to the top of the micro air pump (150) and they are in communication with each other.

5. The exosome brain delivery device based on nasal delivery according to claim 4, characterized in that: The quick-release assembly (220) includes a magnetic sleeve (221) fixedly installed at the end of the hose (210), and a magnetic ring (222) fixedly installed inside the magnetic sleeve (221).

6. The exosome brain delivery device based on nasal delivery according to claim 5, characterized in that: The quick-release assembly (220) also includes a cannula (223) that is movably inserted into the inner cavity of the magnetic sleeve (221), and a duckbill valve (224) that is fixedly installed at the end of the cannula (223).

7. The exosome brain delivery device based on nasal delivery according to claim 6, characterized in that: The gripping mechanism (300) includes a thumb grip (310), a middle finger grip (320) hinged to the end of the thumb grip (310), and a gravity balance assembly (330) disposed on the outside of the middle finger grip (320).

8. The exosome brain delivery device based on nasal delivery according to claim 7, characterized in that: The gripping mechanism (300) further includes a limiting groove (340) opened on the outside of the middle finger grip (320), a groove plate (350) fixedly installed on the outside of the middle finger grip (320), a magnetic sliding piece (360) movably locked in the inner cavity of the groove plate (350), a through hole (370) opened in the inner cavity of the middle finger grip (320), a damping bushing (380) hinged to the end of the thumb grip (310), and a limiting sleeve (390) hinged to the top of the damping bushing (380). The limiting sleeve (390) is movably sleeved on one end of the hose (210) near the delivery mechanism (200).

9. The exosome brain delivery device based on nasal delivery according to claim 8, characterized in that: The gravity balance assembly (330) includes a movable rod (331) that is movably engaged in the inner cavity of the through hole (370), and a limiting ring (332) that is fixedly sleeved on the outside of the movable rod (331).

10. The exosome brain delivery device based on nasal delivery according to claim 9, characterized in that: The gravity balance assembly (330) also includes a return spring (333) fixedly installed on the outside of the limiting ring (332), and a support grip (334) fixedly installed on the end of the return spring (333).